Invirsa, Inc.

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 2

Forward Citations = 14

Loading Chart...

2 inventors (with patents filed for the assignee):

Robert A Shalwitz (6 out of 33 patents)

Anna Kotsakis Ruehlmann (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 12370209 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2025-07-29),

2. 12233083 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2025-02-25),

3. 11857561 - Methods for the use of 5′-adenosine diphosphate ribose (ADPR) (2024-01-02),

4. 11793826 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2023-10-24),

5. 11110112 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2021-09-07),

6. 10946034 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2021-03-16),

Company Overview

Invirsa, Inc. is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of ocular diseases. Their flagship product is a novel medication for the treatment of viral and inflammatory eye conditions. With a strong pipeline of cutting-edge drugs, Invirsa is committed to advancing the field of ophthalmology and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#118 in Columbus, OH

#1,771 in Ohio

#45,063 in US

Columbus, OH, United States of America

Invirsa, Inc.

Forward Citations = 14

2 inventors:

Robert A Shalwitz (6 out of 33 patents)

Anna Kotsakis Ruehlmann (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invirsa, Inc.. Retrieved from https://idiyas.com/company/invirsa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]